The DOI matches its Crossref record; 250 of the 250 references it cites were found in a registry or an index.
Promising Therapeutic Targets for Treatment of Rheumatoid Arthritis
Open accessAbstract
Rheumatoid arthritis (RA) is a systemic poly-articular chronic autoimmune joint disease that mainly damages the hands and feet, which affects 0.5% to 1.0% of the population worldwide. With the sustained development of disease-modifying antirheumatic drugs (DMARDs), significant success has been achieved for preventing and relieving disease activity in RA patients. Unfortunately, some patients still show limited response to DMARDs, which puts forward new requirements for special targets and novel therapies. Understanding the pathogenetic roles of the various molecules in RA could facilitate discovery of potential therapeutic targets and approaches. In this review, both existing and emerging targets, including the proteins, small molecular metabolites, and epigenetic regulators related to RA, are discussed, with a focus on the mechanisms that result in inflammation and the development of new drugs for blocking the various modulators in RA.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
11 retracted
Zheng, J., Zhu, L., In, I. I., Chen, Y., Jia, N., & Zhu, W. (2019) · International Immunopharmacology · doi:10.1016/j.intimp.2019.105985 · Cited by 105
RetractedHao, L., Wan, Y., Xiao, J., Tang, Q., Deng, H., & Chen, L. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.7299 · Cited by 44
RetractedWei, Q., Lv, F., Zhang, H., Wang, X., Geng, Q., Zhang, X., Li, T., Wang, S., Wang, Y., & Cui, Y. (2020) · Bioscience Reports · doi:10.1042/bsr20191136 · Cited by 40
RetractedHu, X., Tang, J., Hu, X., Bao, P., Deng, W., Wu, J., Liang, Y., Chen, Z., Gao, L., & Tang, Y. (2019) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2019.11.015 · Cited by 30
RetractedLi, D., Zhou, Q., Hu, G., & Wang, G. (2019) · Bioscience Reports · doi:10.1042/bsr20182500 · Cited by 22
RetractedQiang, J., Lv, T., Wu, Z., & Yang, X. (2019) · Bioscience Reports · doi:10.1042/bsr20190700 · Cited by 17
RetractedQu, Y., Zhang, Y., Wu, J., Jie, L., Deng, J., Zhao, D., & Yu, Q. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.28390 · Cited by 16
RetractedWang, Z., Xiu, D., Jiang, J., & Liu, G. (2020) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.23496 · Cited by 16
RetractedZhi, L.-Q., Zhong, Q., Ma, J.-B., et al. (2020) · PubMed · doi:10.26355/eurrev_202004_20985 · Cited by 12
RetractedHuang, Y., Chen, K., Yu, H., Chen, D., Deng, L., Zhang, Y., Xue, X., & Pan, X. (2020) · Cell Cycle · doi:10.1080/15384101.2020.1717033 · Cited by 9
Self-citationRetracted
Cited by
Macrophages in immunoregulation and therapeutics
Chen, S., Saeed, A. F. U. H., Liu, Q., Jiang, Q., Xu, H., Xiao, G. G., Rao, L., & Duo, Y. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01452-1 · Cited by 2,229
Management of Rheumatoid Arthritis: An Overview
Radu, A.-F., & Bungau, S. G. (2021) · Cells · doi:10.3390/cells10112857 · Cited by 1,089
Metadata
- Authors
- Huang, J., Fu, X., Chen, X., Li, Z., Huang, Y., & Liang, C.
- Venue
- Frontiers in Immunology
- Publisher
- Frontiers Media SA
- Published
- 2021-07-09
- Volume
- 12
- Pages
- 686155-686155
- ISSN
- 1664-3224 (ISSN-L)
- OpenAlex
- W3181834541
- Cited by
- 340
- References
- 250
- FWCI
- 32.95
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Promising Therapeutic Targets for Treatment of Rheumatoid Arthritis. https://app.cochat.ai/papers/10.3389/fimmu.2021.686155
- The paper
- Huang, J., Fu, X., Chen, X., Li, Z., Huang, Y., & Liang, C. (2021). Promising Therapeutic Targets for Treatment of Rheumatoid Arthritis. Frontiers in Immunology. https://doi.org/10.3389/fimmu.2021.686155
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.